Johns

  • Qiagen Acquires License for Key PI3K Gene

    Qiagen has announced that its wholly owned subsidiary DxS has acquired the global and exclusive license for biomarker PI3K from Johns Hopkins University, to develop real-time Polymerase Chain Reaction (RT-PCR) and endpoint PCR assays. Research has sh…

    Johns | 26 February 2010

  • Vermillion and Johns Hopkins To Develop Molecular Diagnostic Tests

    Vermillion, Inc., a high-value molecular diagnostics company, has announced the renewal of a long-standing collaboration with Johns Hopkins University on the development of novel biomarkers that can be applied toward disease detection, classification…

    Johns | 26 February 2008